DGAP-News

BRAIN AG appoints experienced corporate finance specialist to the Board of Management

DGAP-News: B.R.A.I.N. Biotechnology Research And Information Network AG /
Key word(s): Change of Personnel
BRAIN AG appoints experienced corporate finance specialist to the Board of
Management

26.09.2016 / 08:30
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

PRESS RELEASE

BRAIN AG appoints experienced corporate finance specialist to the Board of
Management

- Frank Goebel appointed to the Board of Management of BRAIN AG as of 1
November 2016

- Eric Marks to leave the Board of Management of BRAIN AG for personal
reasons as of 31 October 2016

- BioIndustrial Segment to be expanded in a consistent manner

- M&A activities to become the direct responsibility of the BRAIN Group's
Board of Management

Zwingenberg, 26 September 2016: Changes to the Board of Management and the
management team were pushed forward at the ordinary meeting of the
Supervisory Board of B.R.A.I.N. Biotechnology Research and Information
Network AG ("BRAIN AG"; ISIN DE0005203947 / WKN 520394) on 23 September
2016. Frank Goebel (46) will be appointed to the Board of Management of
BRAIN AG as per 01 November 2016, thus moving from the position of Managing
Director of BRAIN Capital GmbH, which he has held since February 2015, to
the Group Board of Management. This step will anchor the group's M&A
activities, which are crucial for the company's forward integration,
directly in the group's Board of Management.

The creation or expansion of direct ways to access the B2B market as well
as the establishment or extension of sales expertise are building blocks
intended to promote the company's industrialization strategy and to tap
growth opportunities in the BioIndustrial B2B product business. Besides the
group's M&A activities, Frank Goebel will also take over responsibility for
corporate investment management, i.e. the management of the BRAIN Group's
subsidiaries, in order to facilitate an interconnection of the various
subsidiaries' management and thus make even more use of the synergy
potentials within the corporate portfolio. "I am eagerly anticipating this
exciting new challenge. In the past two years, I have already been able to
gain a comprehensive view of the company, and I do see a clear potential
for growth. In future, I would like to cooperate even more closely with our
subsidiaries in order to continuously expand the industrialization of the
BRAIN Group," says Frank Goebel, designated member of BRAIN AG's Board of
Management. Adds Dr Jürgen Eck, CEO of BRAN AG: "I am looking forward to